Patents by Inventor Baozhi Yuan

Baozhi Yuan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230312755
    Abstract: The present application provides anti-Sclerostin constructs that bind to Sclerostin (e.g., anti-Sclerostin antibodies, e.g., bispecific anti-Sclerostin antibodies), nucleic acid molecules encoding an amino acid sequence of the anti-Sclerostin, vectors comprising the nucleic acid molecules, host cells containing the vectors, methods of preparing the anti-Sclerostin construct, pharmaceutical compositions containing the anti-Sclerostin construct, and methods of using the anti-Sclerostin construct or compositions.
    Type: Application
    Filed: November 7, 2022
    Publication date: October 5, 2023
    Applicant: ANGITIA BIOPHARMACEUTICALS GUANGZHOU LIMITED
    Inventors: Xiaofeng LIU, Kunfeng LIU, Baozhi YUAN, Muyu LI, Hua Zhu KE
  • Publication number: 20170073369
    Abstract: The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject.
    Type: Application
    Filed: November 8, 2016
    Publication date: March 16, 2017
    Inventors: Marc K. DREZNER, Baozhi YUAN
  • Patent number: 9511111
    Abstract: The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject. The methods comprise administering to the subject an effective amount of a polyarginine peptide.
    Type: Grant
    Filed: March 13, 2015
    Date of Patent: December 6, 2016
    Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION
    Inventors: Marc K. Drezner, Baozhi Yuan
  • Publication number: 20150258165
    Abstract: The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject.
    Type: Application
    Filed: March 13, 2015
    Publication date: September 17, 2015
    Inventors: Marc K. DREZNER, Baozhi YUAN
  • Patent number: 8993720
    Abstract: The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject. The methods comprise administering to the subject an effective amount of a polyarginine peptide.
    Type: Grant
    Filed: October 13, 2011
    Date of Patent: March 31, 2015
    Assignee: Wisconsin Alumni Research Foundation
    Inventors: Marc K. Drezner, Baozhi Yuan
  • Publication number: 20120122790
    Abstract: The disclosure provides methods of treating X-linked hypophosphatemia, related bone demineralization and renal phosphate wasting disorders in a mammalian subject.
    Type: Application
    Filed: October 13, 2011
    Publication date: May 17, 2012
    Inventors: Marc K. DREZNER, Baozhi Yuan